Anthropic's Push Into AI Drug Discovery and Medical Research

The release of Claude Science marks a new era for AI leader Anthropic as it positions itself as a critical tool for researchers engaged in drug discovery

AI has the potential to rapidly accelerate the pace of drug discovery and the development of healthcare interventions.

With the release of Claude Science, this potential could soon evolve into practical reality for all Claude paid subscribers.

Anthropic's "AI workbench for scientists" aims to support medical researchers by providing open access to an AI agent equipped with more than 60 curated skills and connectors spanning a range of life science disciplines, all within an interface designed for the unique demands of scientific research.

Anthropic will also leverage its new product to pursue its own research and drug development programmes for rare and neglected diseases.

"We're doing this because we believe first and foremost that to build the right models, products and tools to accelerate the industry, we need to live it along with all of you," says Eric Kauderer-Abrams, Head of Life Sciences at Anthropic.